NASDAQ:SBC - Nasdaq - US73245B1070 - Common Stock - Currency: USD
NASDAQ:SBC (6/25/2025, 9:30:00 AM)
4.27
0 (0%)
The current stock price of SBC is 4.27 USD. In the past month the price decreased by -6.15%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CVS | CVS HEALTH CORP | 10.5 | 84.44B | ||
CI | THE CIGNA GROUP | 11.33 | 83.54B | ||
LH | LABCORP HOLDINGS INC | 17.77 | 21.91B | ||
DGX | QUEST DIAGNOSTICS INC | 19.47 | 19.97B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 14.58 | 16.17B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 130.18 | 14.06B | ||
DVA | DAVITA INC | 15.22 | 10.62B | ||
HIMS | HIMS & HERS HEALTH INC | 64.8 | 10.01B | ||
CHE | CHEMED CORP | 23.66 | 8.16B | ||
GH | GUARDANT HEALTH INC | N/A | 6.23B | ||
CRVL | CORVEL CORP | 57.52 | 5.38B | ||
OPCH | OPTION CARE HEALTH INC | 26.01 | 5.28B |
SBC Medical Group Holdings, Inc. engages in management services and products to cosmetic treatment centers. The company is headquartered in Irvine, California and currently employs 863 full-time employees. The company went IPO on 2022-09-26. The firm is primarily focused on providing comprehensive management services to franchisee clinics, including, but not limited to, advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumable's procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensure of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.
SBC MEDICAL GROUP HOLDINGS I
200 Spectrum Center Dr., Suite 300
Irvine CALIFORNIA US
Employees: 863
Phone: 19495930250
The current stock price of SBC is 4.27 USD.
The exchange symbol of SBC MEDICAL GROUP HOLDINGS I is SBC and it is listed on the Nasdaq exchange.
SBC stock is listed on the Nasdaq exchange.
null analysts have analysed SBC and the average price target is 6.13 USD. This implies a price increase of 43.56% is expected in the next year compared to the current price of 4.27. Check the SBC MEDICAL GROUP HOLDINGS I stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SBC MEDICAL GROUP HOLDINGS I (SBC) has a market capitalization of 442.41M USD. This makes SBC a Small Cap stock.
SBC MEDICAL GROUP HOLDINGS I (SBC) currently has 863 employees.
SBC MEDICAL GROUP HOLDINGS I (SBC) has a support level at 4.26 and a resistance level at 4.49. Check the full technical report for a detailed analysis of SBC support and resistance levels.
The Revenue of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -9.42% in the next year. Check the estimates tab for more information on the SBC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SBC does not pay a dividend.
SBC MEDICAL GROUP HOLDINGS I (SBC) will report earnings on 2025-09-21.
The PE ratio for SBC MEDICAL GROUP HOLDINGS I (SBC) is 9.28. This is based on the reported non-GAAP earnings per share of 0.46 and the current share price of 4.27 USD. Check the full fundamental report for a full analysis of the valuation metrics for SBC.
The outstanding short interest for SBC MEDICAL GROUP HOLDINGS I (SBC) is 0.72% of its float. Check the ownership tab for more information on the SBC short interest.
ChartMill assigns a technical rating of 4 / 10 to SBC.
ChartMill assigns a fundamental rating of 6 / 10 to SBC. SBC has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months SBC reported a non-GAAP Earnings per Share(EPS) of 0.46. The EPS increased by 383.61% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 24.94% | ||
ROA | 17.34% | ||
ROE | 21.8% | ||
Debt/Equity | 0.03 |
For the next year, analysts expect an EPS growth of 8.4% and a revenue growth -9.42% for SBC